These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 15686463)
1. Prediction of haemorrhage in the early stage of acute myeloid leukaemia by flow cytometric analysis of platelet function. Leinoe EB; Hoffmann MH; Kjaersgaard E; Nielsen JD; Bergmann OJ; Klausen TW; Johnsen HE Br J Haematol; 2005 Feb; 128(4):526-32. PubMed ID: 15686463 [TBL] [Abstract][Full Text] [Related]
2. Multiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia. Leinoe EB; Hoffmann MH; Kjaersgaard E; Johnsen HE Br J Haematol; 2004 Oct; 127(1):76-84. PubMed ID: 15384980 [TBL] [Abstract][Full Text] [Related]
3. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers. Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515 [TBL] [Abstract][Full Text] [Related]
4. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure. Chung I; Choudhury A; Patel J; Lip GY Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353 [TBL] [Abstract][Full Text] [Related]
5. Platelet function following acute cerebral ischemia. Smout J; Dyker A; Cleanthis M; Ford G; Kesteven P; Stansby G Angiology; 2009; 60(3):362-9. PubMed ID: 19398427 [TBL] [Abstract][Full Text] [Related]
6. [Flow cytometric 3-color analysis of circulating activated platelets and its clinical significance in ischemic cerebrovascular diseases]. Wang J; Cao L; He M Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):499-502. PubMed ID: 11798806 [TBL] [Abstract][Full Text] [Related]
7. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation. Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652 [TBL] [Abstract][Full Text] [Related]
8. The influence of VIP and epoprostenol on platelet CD62P expression and primary haemostasis in vitro. Zwerina J; Landsteiner H; Leitgeb U; Volf I; Petkov V; Zimpfer M; Blaicher A Platelets; 2004 Feb; 15(1):55-60. PubMed ID: 14985177 [TBL] [Abstract][Full Text] [Related]
10. Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters. Dijkstra-Tiekstra MJ; Pietersz RN; Huijgens PC Vox Sang; 2004 Nov; 87(4):257-63. PubMed ID: 15585021 [TBL] [Abstract][Full Text] [Related]
11. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke. Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Wang HC; Lee TH; Lu CH Thromb Res; 2009 Jun; 124(2):213-8. PubMed ID: 19233449 [TBL] [Abstract][Full Text] [Related]
12. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Purdy G; Lawrie AS; Watt H; Brown MM; Machin SJ Br J Haematol; 2004 Jun; 125(6):777-87. PubMed ID: 15180868 [TBL] [Abstract][Full Text] [Related]
13. Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion. Lim YA; Cho SR; Lee WG; Park JS; Kim SW Platelets; 2008 Aug; 19(5):328-34. PubMed ID: 18791938 [TBL] [Abstract][Full Text] [Related]
14. Quantification of platelet activation status by analyzing P-selectin expression. Leytin V; Mody M; Semple JW; Garvey B; Freedman J Biochem Biophys Res Commun; 2000 Jul; 273(2):565-70. PubMed ID: 10873646 [TBL] [Abstract][Full Text] [Related]
15. [Detection of platelet activation]. Matsuno K Rinsho Byori; 1995 May; 43(5):432-7. PubMed ID: 7540228 [TBL] [Abstract][Full Text] [Related]
16. Haemostatic derangement in advanced peripheral occlusive arterial disease. Koksch M; Zeiger F; Wittig K; Pfeiffer D; Ruehlmann C Int Angiol; 1999 Dec; 18(4):256-62. PubMed ID: 10811512 [TBL] [Abstract][Full Text] [Related]
17. Detection of activated platelets in canine blood by use of flow cytometry. Wills TB; Wardrop KJ; Meyers KM Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212 [TBL] [Abstract][Full Text] [Related]
18. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Tan KT; Tayebjee MH; Lim HS; Lip GY Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308 [TBL] [Abstract][Full Text] [Related]
19. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction. Lee KW; Blann AD; Lip GY Am J Hypertens; 2005 Jan; 18(1):104-15. PubMed ID: 15691624 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial. Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]